TAMM Net
TAMM Net is a boutique Atlanta-based clinical research organization that provides regulatory, reimbursement, prior authorization, HEOR, and clinical trial services to medical device and biomedical innovators. Founded in 2009, it was acquired by Walnut Hill Medical in April 2026.
- Company typePrivate
- Founded2009
- HeadquartersAtlanta, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What TAMM Net does
TAMM Net is a boutique clinical research organization (CRO) founded in 2009 in Atlanta, Georgia, by Arthur F. Spalding, providing integrated regulatory, reimbursement, and clinical development services to medical device manufacturers and biomedical innovators. Its service portfolio spans Regulatory and Quality (FDA 510(k) submissions, IDE approvals, CE Mark filings, Quality Management System development), Managed Markets and Reimbursement (coding strategies, payer assessments, C-code applications), Prior Authorization support, Health Economics Outcomes Research, Clinical Research Services (trial design, protocol authoring, principal investigator recruitment, FDA IDE submissions), and a Reimbursement Support Call Center for prior authorizations, benefits verification, and sales force support. The firm operates a proprietary multi-step process framework (8-18 steps) covering Discovery and Requirements, Planning and GAP Analysis, Implementation, Delivery, and Close and Continuation phases.
The business model is professional services revenue, with quote-based, customized engagements sold through direct consultative B2B sales to medical device companies ranging from pre-commercial startups (CivaTech, Atlanta Catheter Therapies, Revolutions Medical, Augment Health, H Robotics, Pro2Cool TecTraum, BioChip Labs, ImmutriX Therapeutics) to mid-market players (Myelotec) and enterprise/government-adjacent clients (Wright Brothers Institute). The company generates revenue across three streams: Regulatory and Quality Services, Reimbursement and Market Access Services, and Clinical Development and Research Services, each priced per engagement rather than through published rate cards. Marketing is conducted via the company website, client testimonials, case studies, and industry recognition, including the 2022 Globe Award from the Georgia Department of Economic Development for international market expansion.
On April 1, 2026, Walnut Hill Medical acquired TAMM Net, with founder and CEO Art Spalding transitioning to Chief Operating Officer of the acquiring organization. Following the transaction, the TAMM Net brand has been folded into Walnut Hill Medical, positioning the CRO's regulatory, reimbursement, prior authorization, and provider training capabilities within a larger commercialization-focused organization serving emerging and commercial-stage medical device companies.
TAMM Net firmographics
Firmographics- Name
- TAMM Net
- Legal name
- TAMM Net, Inc.
- Website
- https://tammnet.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- TAMM Net is a boutique Atlanta-based clinical research organization that provides regulatory, reimbursement, prior authorization, HEOR, and clinical trial services to medical device and biomedical innovators. Founded in 2009, it was acquired by Walnut Hill Medical in April 2026.
- Ownership category
- akta.pro rank
TAMM Net industry classification
Industry- Product category
- Medical Device Regulatory and Reimbursement Consulting (CRO Services)
- NAICS
- Other Scientific and Technical Consulting Services (541690), All Other Professional, Scientific, and Technical Services (54199)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Clinical Trial Supply, Logistics & Vendor Management FSP (HLAGAOAH)
Keywords
Where TAMM Net is headquartered
LocationHeadquarters
- HQ city
- Atlanta
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
TAMM Net business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Regulatory and Quality Services: Regulatory strategy development, FDA submissions, 510(k) applications, IDE approvals, and quality management system development for medical device manufacturers.
- Reimbursement and Market Access Services: Managed markets strategy, prior authorization support, reimbursement guides, coding applications (C-codes), and payer assessments to help clients achieve reimbursement for their products.
- Clinical Development and Research Services: Clinical trial design and conduct, protocol development, principal investigator recruitment, and FDA interaction support for regulatory clearance.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
TAMM Net product offering
Product offeringCore offering
TAMM Net is a boutique clinical research organization that delivers integrated regulatory and market access services to biomedical manufacturers from concept through commercialization. Its core offerings include Regulatory and Quality services (FDA submissions, 510(k), CE Mark, QMS development), Managed Markets and Reimbursement (coding, payer assessments, prior authorization, reimbursement call center), Health Economics Outcomes Research, and Clinical Research Services (trial design, protocol authoring, IDE submissions, PI recruitment).
Product overview
TAMM Net is a boutique Clinical Research Organization (CRO) providing integrated regulatory and market access services to biomedical manufacturers. The company operates as a single unified service offering encompassing Regulatory & Quality (FDA submissions, CE Mark, quality management systems), Managed Markets & Reimbursement, Prior Authorization Services, Health Economics Outcomes Research, Reimbursement Support Call Center, and Clinical Research Services. The company was acquired by Walnut Hill Medical in April 2026, with CEO Art Spalding becoming COO of the acquiring company.
Differentiator
Problem solved
Functional benefit
Products and services
- Regulatory and Quality Services
Quantifiable outcome
- $244,479 grant obtained on first application for Atlanta Catheter Therapies
- +2 more outcomes
Companies that use TAMM Net
Customer profileNamed customers10 records
Segments2 records
Ideal customer profiles2 records
TAMM Net technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
TAMM Net partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Walnut Hill MedicalcoreWalnut Hill Medical acquired TAMM Net, finalizing the transaction on April 1, 2026. The acquisition strengthens WHM's capabilities in regulatory submissions, reimbursement strategy, prior authorization support, and provider training—functions critical for medical device commercialization and sustained market access. As part of the transaction, TAMM Net CEO Art Spalding joined Walnut Hill Medical as Chief Operating Officer. The combined organization aims to better serve emerging innovators and commercial-stage medical device companies seeking disciplined commercialization execution in complex markets.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
TAMM Net competitors and assessment
Company assessmentDirect peers
- NAMSA: NAMSA is the largest medical device-focused CRO providing regulatory, clinical, and quality consulting for medtech manufacturers. Directly comparable to TAMM Net as a medtech-specialized services firm, though significantly larger in scale and global footprint.
- MCRA (Musculoskeletal Clinical Regulatory Advisers): MCRA is a leading medtech-focused regulatory, clinical, and reimbursement consultancy serving device manufacturers across multiple therapeutic areas. Closely mirrors TAMM Net's integrated regulatory + reimbursement + clinical offering for emerging and commercial-stage medtech clients.
- Veranex: Veranex is a medtech CRO offering regulatory, clinical, design, and commercialization services to medical device innovators. Comparable to TAMM Net's end-to-end commercialization support stack for medical device manufacturers.
- RCRI (Regulatory & Clinical Research Institute): RCRI provides regulatory affairs, clinical research, and quality systems consulting specifically to medical device and combination product companies. Direct peer in medtech-focused boutique consulting with overlapping service lines.
- Boston MedTech Advisors: Boston MedTech Advisors is a medtech consultancy providing regulatory, reimbursement, and clinical strategy to device manufacturers. Comparable boutique positioning and service mix to TAMM Net for emerging medtech clients.
- MEDIcept: MEDIcept is a regulatory, quality, and clinical consulting firm serving medical device and combination product manufacturers. Overlapping service portfolio with TAMM Net, particularly in regulatory submissions and quality systems development.
Broad incumbents
- IQVIA: IQVIA is a global CRO and life sciences services giant offering regulatory, clinical, and commercial services across pharma and medtech. Operates broadly in the same space as TAMM Net but at significantly greater scale and with broader therapeutic and geographic coverage.
- Medpace: Medpace is a mid-to-large CRO providing full-service clinical development and regulatory support to biopharma and medtech sponsors. Comparable regulatory and clinical offerings, though with broader scale and a pharma-heavy mix.
- Premier Research: Premier Research is a global CRO serving biotech, pharma, and medtech with regulatory and clinical services. Overlapping medtech regulatory and clinical trial service lines with TAMM Net at a broader scale.
Emerging players
- Advarra: Advarra provides clinical research services including IRB review, biosafety, and clinical technology to medtech and biopharma sponsors. Partial overlap with TAMM Net's clinical research offering for device manufacturers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
TAMM Net social profiles
Digital presenceTAMM Net financial estimates
Financial estimateRevenue estimate
Valuation estimate
TAMM Net leadership team
Management profileNumber of profiles
TAMM Net funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TAMM Net M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TAMM Net
What does TAMM Net do?
TAMM Net is a boutique clinical research organization that delivers integrated regulatory and market access services to biomedical manufacturers from concept through commercialization. Its core offerings include Regulatory and Quality services (FDA submissions, 510(k), CE Mark, QMS development), Managed Markets and Reimbursement (coding, payer assessments, prior authorization, reimbursement call center), Health Economics Outcomes Research, and Clinical Research Services (trial design, protocol authoring, IDE submissions, PI recruitment).
Is TAMM Net a public or private company?
TAMM Net is a private company. It is classified as corporate owned and is currently acquired.
When was TAMM Net founded?
TAMM Net was founded in 2009. It employs 11 to 50 people.
Where is TAMM Net based?
TAMM Net is headquartered in Atlanta, United States, in the North America region.
How does TAMM Net make money?
Three revenue lines are on record. Regulatory and Quality Services are the primary driver. The others are reimbursement and Market Access Services and clinical Development and Research Services.
Who are TAMM Net's main competitors?
Direct peers on record are NAMSA, MCRA (Musculoskeletal Clinical Regulatory Advisers), Veranex, RCRI (Regulatory & Clinical Research Institute), Boston MedTech Advisors and MEDIcept. Broad incumbents are IQVIA, Medpace and Premier Research. Advarra is listed as an emerging player.
Does TAMM Net have an API?
No public API is recorded for TAMM Net.
What industry is TAMM Net in?
TAMM Net's product category is Medical Device Regulatory and Reimbursement Consulting (CRO Services). Its primary akta.pro industry code is HLAGAOAH, Clinical Trial Supply, Logistics & Vendor Management FSP. Its NAICS code is 541690 and its SIC code is 8000.